www.fdanews.com/articles/86412-sarasin-cuts-clariant-estimates-after-sale
SARASIN CUTS CLARIANT ESTIMATES AFTER SALE
April 28, 2006
Clariant restructuring still has some way to go, following divestment of pharmaceutical fine chemicals, says Sarasin. Cuts '06 EPS estimates by nearly 19% to account for expected book loss to CHF1 per share, but sees no impact on '07 estimates and DFCF price target of CHF18.
Newratings (http://www.newratings.com/analyst_news/article_1261907.html)